Antibiotics Market Expected to Reach USD 67.88 Billion by 2030, Fueled by Surge in AMR Awareness and Demand for Targeted Treatments

Mordor Intelligence has published a new report on the Antibiotics Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global antibiotics market is positioned for steady growth, expanding from USD 55.60 billion in 2025 to an estimated USD 67.88 billion by 2030, with a compound annual growth rate (CAGR) of 4.07%. This progression reflects elevated focus on managing infectious diseases, balancing stewardship concerns, and addressing rising antimicrobial resistance (AMR). Demand is driven by hospital-acquired infections, broader healthcare access, and regulatory efforts promoting new classes of antibiotics.

Report Overview: https://www.mordorintelligence.com/industry-reports/antibiotics-market?utm_source=openpr

Key Trends

Antimicrobial Resistance Pressure: AMR continues to be a major public health challenge, prompting investment in new antibiotic classes and stricter stewardship protocols. This factor adds an estimated +3.1% impact on CAGR globally.

Shifting Demand toward Narrow-Spectrum Agents: While broad-spectrum antibiotics currently account for the largest share (68.1% in 2025), there is growing interest in narrow-spectrum drugs given their lower impact on the microbiome and resistance risk. Narrow-spectrum agents are expected to grow at around 6.1% CAGR by 2030.

Pricing Advantage of New Therapies: Clinical buyers and payers show greater willingness to invest in newer antibiotics with proven efficacy against multi‐drug resistant pathogens, particularly where stewardship value is demonstrable.

Epidemiological Shifts and Hospital Infections: Increase in hospital-acquired infections, especially in tertiary care settings across emerging economies, is adding to antibiotic consumption (+0.8% impact on CAGR)

Market Segmentation

This section outlines how the market divides across product types, spectrum profile, and regional markets:

By Product Type

Cephalosporins

Penicillins


Fluoroquinolones

Macrolides

Carbapenems

Aminoglycosides

Sulfonamides

Other Product Types

By Spectrum

Broad-spectrum Antibiotics

Narrow-spectrum Antibiotics


By Geography:

North America

Europe

Asia‐Pacific

South America

Middle East & Africa


These segments illustrate the balance between established drug classes and newer antibiotic agents gaining traction due to clinical and regulatory preference.

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr


Key Players

The antibiotics market remains moderately concentrated, led by multinational pharmaceutical firms with broad manufacturing capabilities and global distribution networks:

Pfizer Inc.

Merck & Co., Inc.

Novartis AG (Sandoz)

Bayer AG

GlaxoSmithKline plc

These companies lead through extensive portfolios covering penicillins, cephalosporins, macrolides, tetracyclines, and newer agents. They maintain relationships with hospital systems and health ministries and often engage in research regarding narrow-spectrum agents and AMR mitigation strategies.

For More information visit: https://www.mordorintelligence.com/industry-reports/antibiotics-market/companies?utm_source=openpr

Conclusion

With the antibiotics market forecast to grow from USD 55.60 billion in 2025 to USD 67.88 billion by 2030, the outlook remains cautious but forward moving. Growth reflects multiple converging factors: a heightened healthcare burden from infectious diseases, global initiatives addressing AMR, and a shift toward targeted antibiotic use. Cephalosporins retain the largest share, while carbapenems and narrow-spectrum agents capture rising interest. Asia‐Pacific continues to dominate in size, and regions like the Middle East & Africa register the fastest expansion.

The market operates in a tension between therapeutic necessity and the need to control resistance. Buyers and regulators favor products that offer a measurable stewardship advantage. For leading manufacturers, this means placing emphasis on developing next-gen antibiotics that meet both clinical demand and public health objectives.

Industry Related Reports

Peptide Antibiotics Market: The Peptide Antibiotics Market is Segmented by Product Type (Ribosomal-Synthesised and Non-Ribosomal-Synthesised), Disease (Skin Infections, HABP/VABP, and More), Route of Administration (Injectable, Topical, and More), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and More), and Geography (North America, Europe, Asia-Pacific, and More).

Get More Insights: https://www.mordorintelligence.com/industry-reports/peptide-antibiotics-market?utm_source=openpr


Antibiotic Resistance Market: The Antibiotic Resistance Market is Segmented by Disease (CDI, CIAI, and More), Pathogen (A. Baumannii, P. Aeruginosa, and More), Drug Class (Tetracyclines, and More), Mechanism of Action (Cell-Wall Synthesis Inhibitors, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, Asia Pacific, and More).

Get More Insights: https://www.mordorintelligence.com/industry-reports/antibiotic-resistance-market?utm_source=openpr


Veterinary Antibiotics Market: The Veterinary Antibiotics Market is Segmented by Animal Type (Poultry, and More), Drug Class (Tetracyclines, and More), Delivery Form (Premixes, and More), Spectrum of Activity (Broad-Spectrum and More), End User (Food-Producing Animal Producers and More), Distribution Channel (Veterinary Hospitals and More), and Geography (North America, Europe, and More).

Get More Insights: https://www.mordorintelligence.com/industry-reports/veterinary-antibiotics-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.